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treated with b/fEVAR at Uppsala University Hospital 2010 e2015. Patient
records and administrative data were examined to assess health care re-
sources used and material cost. Cost and resources for all adjunctive pre-
paratory procedures (such as access operation, debranching, and staged
aortic procedures) as well as all related post-operative procedures (such as
extension and relining of stent grafts) were included in the analysis.
Results: A total of 56 patients were included (19 women), mean age 72
years (range 52e83), average aneurysm size 62 mm (range 36e98). The
patients were ASA class 2 (n ¼ 11), 3 (n ¼ 36) and 4 (n ¼ 9). Pre-operative
risk factors included cardiac (n ¼ 31), pulmonary (n ¼ 22), cerebrovascular
(n ¼ 8), renal disease (n ¼ 5) and previous aortic surgery (n ¼ 17).
Aneurysm types were TAAA type I n ¼ 1, II n ¼ 10, III n ¼ 4, IV n ¼ 9,
JPRAA n ¼ 32. Treatment was performed with f-EVAR n ¼ 38, b-EVAR
n ¼ 12 and f/b-EVAR n ¼ 6. Mortality was 3.6% at 30 days (TAAA 4.2%,
JPRAA 3.1%) and 19% at 1 year (TAAA 33.3%, JPRAA 8.3%). Post-operative
complications included cardiac event (n ¼ 7), cerebrovascular event (n ¼ 5,
4 permanent), renal impairment (n ¼ 6, 4 permanent), paraplegia (n ¼ 4, 1
permanent), and graft-occlusion (n ¼ 4, 3 symptomatic). Median total
hospital-stay (for all procedures) was 26 days (range 2e114) for TAAA and 8
days (2e50) for JPRAA. Median time spent in ICU was 0.9 days (0e42) for
TAAA and 0 days (0e43) for JPRAA. Median operating time for the main
procedure was 464 minutes (101 e1025) for TAAA and 273 minutes (62e
677) for JPRAA, and for the adjunctive procedures was 97 minutes (10 e
734) for TAAA, and 0 minutes (0e1609) for JPRAA. The estimated total cost
for hospital stay, intensive care, anaesthesiology, surgeries and materials
was 117971 V for TAAA and 63362 V for JPRAA. Average material cost
including stent grafts was 34625V for TAAA, and 23732V for JPRAA.
Conclusion: Endovascular treatment of complex aortic aneurysms re-
sults in acceptable clinical outcome, but is associated with high cost and
resource utilisation. Stent grafts and material stand for 1/3 of the treat-
ment cost in these patients.
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Introduction: Evaluation of clinical and sports results of surgical treatment
of iliofemoral arterial occlusive lesions. Long-term follow up of an operated
high level athlete cohort.
Methods: From 1991 to 2013, 56 women and 435 men (mean
age ¼ 34  11 years) were operated on for a symptomatic iliofemoral
arterial occlusive disease in a single vascular institution. They were 26
professional athletes, 235 amateur competitors and 230 amateurs. 427
were cyclists (87%), 38 were triathletes (8%), 23 were long-distance run-
ners (5%) and 3 were practicing another sport. Bilateral surgery was per-
formed in 43 patients (8.7%). Pain during supra-maximal exercise, limb
claudication and sub-acute ischemia were diagnosed in 475 (89%), 47 (9%)
and 12 cases (2%) respectively. External iliac artery lesions were the most
frequent (428 lesions, 67%). Locations were multiple in 103 cases (19% of
procedures). The surgical indications were: a stenotic endoﬁbrosis in 463
cases (87%), a native iliac thrombosis in 37 cases (7%), an unsuccessful
endoﬁbrosectomy or bypass performed in another center in 34 cases (6%).
The surgical procedure consisted of an endoﬁbrosectomy with patch in 332
cases (62%), a venous calibrated iliofemoral bypass in 202 cases (38%). 10
iliac PTA without stenting, prior to the optimal surgical treatment (average
delay of 4.2 months) were performed, with the aim ﬁnishing sports season.
An antiplatelet therapy was prescribed for 6 months or for life. Medical
data and duplex-scan follow ups were kept prospectively in a database and
analyzed.
Results: A 28 years-old professional patient died three weeks after an
endoﬁbrosectomy, of iliac rupture because he retrained too early. A post-
operative thrombosis required an iliac thrombectomy in 11 cases. This
procedure was associated 1 times with a popliteal thrombectomy. 26 pa-
tients were lost to follow up within 3 years. The mean follow up was
15.7  7.5 years. Sport resumption was possible in 97%. The mean delayfor athletic recovery was 3.2  1.5 months. Long-term athletic perfor-
mances were improved at 3, 5 and 7 years, 97%, 95% and 91% respectively.
Iliac revascularization, endoﬁbrosectomy and iliofemoral bypass primary
actuarial patencies were at 3, 5 and 10 years: 97%, 96%, 94%/96%, 94%,
92%/98%, 98% and 95% respectively. Secondary patencies were 100%. No
predictive factor of failure was found.
Conclusion: The long-term beneﬁts of iliofemoral revascularizations are
good. They validate surgical indications. However, a sports rehabilitation
protocol and a strict selection of the indications must be further conﬁrmed.
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Introduction: To investigate renal outcomes following endovascular repair
of thoraco-abdominal aneurysms (TAAA) with renal fenestrated or
branched endografts.
Methods: Renal outcomes following TAAA endovascular repair per-
formed with renal branches were collected in 5 European high volume
centers and compared with renal outcomes following TAAA endovascular
repair performed with renal fenestrations. Renal re-intervention and oc-
clusion rates and freedom from any renal outcome and death were
analyzed per-patient and per-target vessel.
Results: 449 patients were included in this retrospective study (235
treated with branched devices (BEVAR) and 214 with fenestrated devices
(FEVAR)). 841 renal vessels were analyzed (436 perfused by branches and
411 by fenestrations). Both groups were comparable except for sex,
smoking habit and anti-vitamin K treatment. Technical success rate was
98.7% and 99.1% respectively.
The mean follow up was 19.2 months (SD 18.2) after BEVAR and 24.3
months (SD 20.6) after FEVAR. During follow up, renal re-intervention rates
were similar in both groups (4.7% vs. 5.2%). The renal occlusion rate was
signiﬁcantly higher following BEVAR (9.4% vs. 2.3%, P ¼ 0.002), and the 2-
year freedom for renal occlusion rate was 94.4% (SE, 92.2%-96.6%)
following BEVAR and 98.9% (SE, 98.1%-99.7%) following FEVAR
(P < 0.001). The 2-year survival rate was 73.4% (SE, 69.8%-77%) and
80.7% (SE, 77.4%-84%) following BEVAR and FEVAR respectively.
Conclusion: Mid-term renal outcomes following endovascular repair of
TAAA are satisfactory. Endograft designs incorporating renal fenestrations
rather than renal branches are associated with signiﬁcantly improved mid-
term patency rates.
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Introduction: Following the pioneering experience and the initial learning
curve, we evaluated the subsequent results in 3 aortic endovascular cen-
tres with signiﬁcant experience (>10 cases) with this new technique.
Methods: Between April 2013 and November 2014, all patients with
arch aneurysms >55 mm deemed unﬁt for open surgery after multidisci-
plinary evaluation, and treated with 2 inner branches endografts, were
included. Inner branches were designed to perfuse the brachiocephalic
trunk and the left common carotid artery (LCC) in all cases. According to
reporting standards, technical success, endoleaks, procedure length, ﬂuo-
roscopy duration and contrast volume injected, early and late complica-
tions and mortality were retrospectively collected in a unique electronic
database.
Results: Twenty-seven patients were included and treated for arch an-
eurysms (70%) or chronic dissections (30%). Technical success was always
achieved. No patients died during the 30 day post-operative period. Early
